During “Direct Measurement of Performance: A New Era in Antimicrobial Stewardship,” the presenters will discuss how ASP key performance indicators are often confounded by factors beyond an ASP’s control.
The AMR Challenge is a way for organizations around the world to collaborate in the fight against antimicrobial resistance. When the challenge launched, bioMérieux made three commitments to the fight against antimicrobial resistance.
Reduction in sepsis mortality is directly dependent on early identification and rapid initiation of appropriate antimicrobial therapy. Fast and accurate diagnosis may also shorten the length of a hospital stay and potentially help reduce the emergence of multidrug-resistant bacteria.